US Drug Recall Register

FDA Drug Recalls

220 recalls · Class I, newest first

Class I · High risk Ongoing

Enoxaparin Sodium Injection

Reason Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)

Apotex Corp. NDC 60505-0795-4 D-0261-2021
Class I · High risk Ongoing

Spironolactone Tablets

Reason Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals NDC 63629-1064-01 D-0303-2021
Class I · High risk Ongoing

Montelukast Sodium Tablets 10 mg

Reason Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.

Hetero Labs Limited Unit V NDC 31722-726-30 D-0081-2019
Class I · High risk Ongoing

Infant 25% DEXTROSE Injection

Reason Presence of Particulate Matter: human hair found within an internal sample syringe.

Hospira Inc. NDC 0409-1775-10 D-0862-2017
Class I · High risk Ongoing

EpiPen Jr. 2-Pak

Reason Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0691-2017
Class I · High risk Ongoing

EpiPen 2-Pak

Reason Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0690-2017
Class I · High risk Ongoing

Bupivacaine Hydrochloride Inj.

Reason Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Hospira Inc., A Pfizer Company NDC 0409-1159-02 D-0218-2017
Class I · High risk Ongoing

Human Chorionic Gonadotropin

Reason Non-sterility - presence of bacteria confirmed by outside laboratory after day 14.

Complete Pharmacy and Medical Solutions LLC D-0918-2017
Class I · High risk Ongoing

Magnesium Sulfate Inj.

Reason Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.

Hospira Inc. NDC 0409-2168-02 D-1137-2016
Class I · High risk Ongoing

8.4% Sodium Bicarbonate Injection

Reason Presence of Particulate Matter: particulate matter identified as an insect in one vial.

Hospira Inc. NDC 0409-6625-02 D-0865-2016
Class I · High risk Ongoing

Human Chorionic Gonadotropin

Reason Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.

Complete Pharmacy and Medical Solutions LLC D-0917-2017
Class I · High risk Ongoing

APEXXX tablets

Reason Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug.

Nuway Distributors, LLC D-0667-2016
Class I · High risk Ongoing

Vitamin Supplement

Reason Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

Glades Drugs Inc. D-0669-2016
Class I · High risk Ongoing

MIRACLE DIET 30 capsules

Reason Marketed Without An Approved NDA/ANDA: Miracle Diet 30 was found to contain undeclared phenolphthalein, a drug product once contained in over-the-counter laxatives but was taken off the U.S. market due to safety concerns, making this product an unapproved drug.

The One Minute Miracle Inc D-0230-2016
Class I · High risk Ongoing

MIRACLE ROCK 48 capsules

Reason Marketed Without An Approved NDA/ANDA: Miracle Rock 48 was found to contain undeclared thiosildenafil, an analogue of an FDA approved drug for male erectile dysfunchtion making this product an unapproved drug.

The One Minute Miracle Inc D-0229-2016
Class I · High risk Ongoing

Zero Xtreme High Performance Fat Burner capsules

Reason Marketed Without an Approved NDA/ANDA: FDA sampling and analysis confirmed the presence of sibutramine and desmethylsibutramine.

Xtreme Z Distributors INC D-1165-2016
Class I · High risk Ongoing

HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS

Reason Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.

Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals NDC 0603-3888-21 D-057-2013
Class I · High risk Ongoing

Blue Male Enhancement Pill

Reason Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug

The Menz Club, LLC D-266-2013